Fushida S, Yonemura Y, Sugiyama K, Matsumoto H, Kamata T, Miwa K, Miyazaki I
Second Department of Surgery, Kanazawa University of Medicine, Japan.
Nihon Geka Gakkai Zasshi. 1988 Dec;89(12):1965-8.
Two hundred and twenty one gastric carcinomas were immunohistochemically stained for h-EGF and we examined the correlation between h-EGF immunoreactivities and histologic findings. Regarding macroscopic and histologic types, incidence of h-EGF immunoreactivities in infiltrating type and in poorly differentiated type was significantly higher than those in localized type and in differentiated type, respectively. In addition, h-EGF producing carcinomas showed high positive rate in prognostic serosal involvement and scirrhous type in stroma. Prognosis in patients with h-EGF producing tumors was poorer than that in those with h-EGF non-producing tumors, especially in stages II and III. These results suggest that h-EGF immunoreactivities serves as a biological marker of high malignancy.
对221例胃癌进行了h-EGF免疫组化染色,并研究了h-EGF免疫反应性与组织学结果之间的相关性。在大体和组织学类型方面,浸润型和低分化型中h-EGF免疫反应性的发生率分别显著高于局限型和高分化型。此外,产生h-EGF的癌在预后性浆膜受累和基质硬癌型中显示出高阳性率。产生h-EGF肿瘤患者的预后比不产生h-EGF肿瘤患者的预后差,尤其是在II期和III期。这些结果表明,h-EGF免疫反应性可作为高恶性的生物学标志物。